Shalby

Shalby EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shalby (SHALBY.NS) as of Oct 21, 2026 is 734.51 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.33 B INR — a change of -44.61% (lower).

EBITDA

734.51 MINR

YoY

-44.61%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shalby is 2026 734.51 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shalby was 2025 1.33 B INR. It decreases by -44.61% lower compared to the previous year.

The Shalby EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
927.34 M INR
Jan 1, 2020
1.00 B INR
Jan 1, 2021
925.24 M INR
Jan 1, 2022
1.24 B INR
Jan 1, 2023
1.41 B INR
Jan 1, 2024
2.76 B INR
Jan 1, 2025
1.33 B INR
Jan 1, 2026
734.51 M INR
The Shalby EBITDA history
YEAREBITDAYoY
734.51 MINR-44.61%
1.33 BINR-51.99%
2.76 BINR+95.48%
1.41 BINR+13.97%
1.24 BINR+33.98%
925.24 MINR-7.62%
1.00 BINR+8.00%
927.34 MINR+0.80%
919.96 MINR+25.53%
732.88 MINR+29.26%
566.97 MINR-18.17%
692.83 MINR+8.50%
638.55 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shalby Stock analysis

What does Shalby do? Shalby Ltd operates hospitals and outpatient clinics in Ahmedabad, Gujarat, with 2,678 full-time employees. The company generates revenue through its Healthcare Services segment, which includes managing hospitals and medical diagnostic services, and its Manufacturing segment focused on producing implants. Key specialties driving demand include joint replacement surgery, critical care, spine surgery, neurology, cardiology, and organ transplants such as kidney and liver procedures. Patients seeking specialized treatments, including ortho-oncology, IVF, and bariatric surgery, form the primary customer base for its healthcare services. The firm's manufacturing division produces medical implants, serving hospitals and clinics under its own brand. Services like homecare, dental cosmetics, and ophthalmology cater to a diverse patient demographic. Revenue streams are derived from both direct patient care and the supply of implants to its own facilities, with no external brands or partnerships mentioned in the business description. Shalby Ltd's business model relies on integrated healthcare delivery across multiple specialties, combining hospital management, diagnostic services, and implant manufacturing. The company's focus on high-demand medical procedures ensures consistent patient flow, while its manufacturing segment supports internal operations without external sales. All services are provided within its owned facilities, emphasizing a vertically integrated approach to healthcare delivery. Shalby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shalby stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shalby is 734.51 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Shalby changed from 1.33 B INR to 734.51 M INR, representing a -44.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Shalby since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Shalby historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Shalby

All Key Metrics — Shalby